BCBSM, Inc. v. Walgreen Co.

CourtDistrict Court, N.D. Illinois
DecidedFebruary 9, 2022
Docket1:20-cv-01853
StatusUnknown

This text of BCBSM, Inc. v. Walgreen Co. (BCBSM, Inc. v. Walgreen Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
BCBSM, Inc. v. Walgreen Co., (N.D. Ill. 2022).

Opinion

THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION BCBSM, INC, (d/b/a BLUE CROSS and BLUE ) SHIELD of MINNESOTA), HEALTH NEW )

YORK, INC, HORIZON HEALTHCARE )

SERVICES, INC. (d/b/a HORIZON BLUE )

CROSS BLUE SHIELD OF NEW JERSEY), )

BLUE CROSS AND BLUE SHIELD OF )

ARIZONA, INC. (d/b/a BLUE CROSS BLUE )

SHIELD OF ARIZONA and d/b/a AZBLUE), ) No. 20 C 1853 ASURIS NORTHWEST HEALTH, et al., ) No. 20 C 1929 ) No. 20 C 3332 Plaintiffs, ) No. 20 C 4940 v. ) No. 20 C 4738 )

WALGREEN CO. and WALGREENS BOOTS )

ALLIANCE, INC., ) Judge Virginia M. Kendall )

Defendants and Third-Party Plaintiffs, )

) v. ) ) PRIME THERAPEUTICS LLC, ) ) Third-Party Defendant. )

MEMORANDUM OPINION AND ORDER The Plaintiffs in this case are health care plans offering comprehensive health care services and coverage, including prescription drug coverage, to their members in locations across the United States. Defendants are Walgreen Co. and Walgreens Boots Alliance, Inc. (together “Walgreens”) who allegedly engaged in a fraudulent scheme to overcharge Plaintiffs for prescription drugs by submitting claims for payment at artificially inflated prices. Walgreens now brings a Verified Counterclaim alleging that Plaintiffs have knowingly aided and abetted Crowell & Moring LLP’s (“Crowell”) breaches of its fiduciary duties to Walgreens, Crowell’s former client. (Dkt. 149 at 179–202). Relatedly, Plaintiffs have filed a “Motion for Qualification of Counsel” seeking an order that Crowell is qualified to serve as their attorneys in this action. (Dkt. 158). Walgreens also brings a Third-Party Complaint (“TPC”) against Prime Therapeutics LLC (“Prime”), one of Plaintiffs’ pharmacy benefit managers (“PBM”), seeking contribution and indemnification. (Dkt. 151).

Now before the Court are three motions. First, Walgreens moves to strike Plaintiffs’ Motion for Qualification of Counsel. (Dkt. 163). Next, Plaintiffs move to dismiss Walgreens’ Counterclaim. (Dkt. 187). Last, Prime moves to dismiss Walgreens Third-Party Complaint. (Dkt. 188). For the reasons set forth below, the Court grants Walgreens’ Motion to Strike [163]; denies Plaintiffs’ Motion to Dismiss Walgreens’ Counterclaim [187]; and grants Prime’s Motion to Dismiss Walgreens’ Third-Party Complaint [188]. BACKGROUND I. Crowell and Walgreens’ Attorney-Client Relationship On a motion to dismiss under Rule 12(b)(6), the Court accepts the complaint’s well- pleaded factual allegations, with all reasonable inferences drawn in the non-moving party’s favor,

but not its legal conclusions. See Smoke Shop, LLC v. United States, 761 F.3d 779, 785 (7th Cir. 2014). Unless otherwise noted, the following factual allegations are taken from Walgreens’ Verified Counterclaim, (Dkt. 149 at 179–202), and are assumed true for purposes of Plaintiffs’ Motion to Dismiss, (Dkt. 187). W. Bend Mut. Ins. Co. v. Schumacher, 844 F.3d 670, 675 (7th Cir. 2016). A. Crowell’s Prior Representation of Walgreens In 2006, Walgreens launched its Prescription Savings Club (“PSC”) program – an initiative that made prescription drugs more affordable for uninsured and underinsured consumers. (Dkt. 149 at 190 ¶ 54). After launching it nationwide in August 2008, Walgreens hired Crowell for legal advice concerning the PSC program in 2008 and 2009. (Id. ¶¶ 55–56). Among other things, Crowell provided legal advice on how prescription prices under the PSC program might affect the usual and customary (“U&C”) prices that Walgreens reports in insurance reimbursement claims. (Id. ¶ 55 (further explaining that U&C prices sometimes cap reimbursements paid by health

insurers for insureds’ prescription drugs)). Walgreens first requested Crowell’s legal advice concerning the PSC program in September 2008. (Id. ¶ 56). Crowell’s assistance related to (1) a proposed pharmacy discount card and (2) a proposed enhancement to Walgreens’ PSC program. (Id. ¶¶ 56–57). Crowell ultimately created and retained privileged work product for Walgreens which included information about the potential impact of discount cards on the U&C prices reported in Walgreens’ reimbursement claims. (Id. at 191 ¶ 59). Walgreens again requested Crowell’s legal advice in October 2008 after receiving a letter from Connecticut Medicaid regarding reporting PSC prices as U&C. (Id. ¶¶ 60–62). Crowell provided counsel regarding Walgreens’ response to this inquiry by reviewing the agency’s letter and reviewing and commenting on Walgreens’ draft response.

(Id. ¶¶ 62–63). Crowell later advised Walgreens on a separate question about U&C prices and PSC in January 2009. (Id. at 192 ¶ 65). Finally, in April 2009, Walgreens requested that Crowell conduct a national survey related to discount card programs and a proposed enhancement to PSC. (Id. ¶ 66 (further noting that Crowell delivered its work product in May and June 2009)). Crowell received privileged and confidential information from Walgreens in connection with its work on these PSC and U&C matters, and Crowell created and retained privileged work product for Walgreens regarding the same. (Id. at 191–93 ¶¶ 58, 63, 70). In addition, Crowell submitted – and Walgreens paid – invoices for this work between October 2008 and July 2009. (Id. at 192 ¶ 67). Walgreens maintains that in light of these facts, it reasonably believed to exist an attorney-client relationship between itself and Crowell between at least the fall of 2008 and mid-2009. (Id. ¶ 70). As a result, per Walgreens, Crowell (1) owes fiduciary duties to Walgreens as a former client, and (2) may not take a materially adverse position to Walgreens in any matter substantially related to the prior representation without Walgreens’ written consent. (Id. at 193–

94 ¶¶ 71, 76, 79 (referring to the ABA Model Rules of Professional Responsibility, the District of Columbia Rules of Professional Conduct, and the Illinois Rules of Professional Conduct)). B. Crowell’s Alleged Breach of Fiduciary Duties In March 2020, Walgreens received two pre-litigation demand letters from Crowell explaining Plaintiffs’ “concern[] that Walgreens has overcharged them by failing to include PSC Program prices in its calculation of U&C prices.” (Id. at 193 ¶¶ 73–74). Crowell subsequently filed suit on Plaintiffs’ behalf alleging that Walgreens defrauded Plaintiffs by failing to include PSC prices in its U&C reporting – including in 2008 and 2009, when Crowell provided Walgreens legal advice about such reporting requirements. (Id. at 194 ¶¶ 77–78; cf. id. at 193 ¶¶ 72 (“[C]ertain Plaintiffs . . . retained Crowell and financially incentivized the law firm to switch sides and

represent them against Walgreens on the very same issues as to which Crowell had previously advised Walgreens.” (emphasis in original)), 75 (“As even Crowell’s March 2020 letters on Plaintiffs’ behalf make clear, Crowell’s current representation of Plaintiffs is substantially related to Crowell’s earlier representation of Walgreens.”)). Walgreens maintains that Crowell’s representation of Plaintiffs in this action violates rules of professional responsibility, because Plaintiffs’ claims relate to substantially similar subject matter of Crowell’s prior representation of Walgreens. (E.g., id. at 194 ¶¶ 76 (“The ABA, the District of Columbia, and Illinois all broadly prohibit lawyers from switching sides to sue a former client on the subject of a prior engagement.”), 79 (“Crowell had an obligation to obtain informed consent from both Walgreens and Plaintiffs before agreeing to this side-switching representation.”); see also id. at 200–01 ¶¶ 103–07 (setting forth Crowell’s fiduciary duty of loyalty)). Walgreens opines that Crowell might “expose its confidential and privileged information about PSC [to Plaintiffs] or use that information to Walgreens’ disadvantage” in this

litigation. (Id. at 195 ¶ 82).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Swanson v. Citibank, N.A.
614 F.3d 400 (Seventh Circuit, 2010)
Reynolds v. CB Sports Bar, Inc.
623 F.3d 1143 (Seventh Circuit, 2010)
Alfred B. Freeman v. Chicago Musical Instrument Co.
689 F.2d 715 (Seventh Circuit, 1982)
Eleanor Schiessle v. Donald E. Stephens
717 F.2d 417 (Seventh Circuit, 1983)
Travelers Insurance Companies v. Penda Corporation
974 F.2d 823 (Seventh Circuit, 1992)
Brewster McCauley v. City of Chicag
671 F.3d 611 (Seventh Circuit, 2011)
Nationwide Insurance v. Zavalis
52 F.3d 689 (Seventh Circuit, 1995)
David Brown v. Timothy Budz
398 F.3d 904 (Seventh Circuit, 2005)
Meridian Security Insurance Co. v. David L. Sadowski
441 F.3d 536 (Seventh Circuit, 2006)
Reichle v. Howards
132 S. Ct. 2088 (Supreme Court, 2012)
Burks v. Raemisch
555 F.3d 592 (Seventh Circuit, 2009)
Man-Seok Choe v. Torres
525 F.3d 733 (Ninth Circuit, 2008)
NFC, INC. v. General Nutrition, Inc.
562 F. Supp. 332 (D. Massachusetts, 1983)
Harsh International, Inc. v. Monfort Industries, Inc.
662 N.W.2d 574 (Nebraska Supreme Court, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
BCBSM, Inc. v. Walgreen Co., Counsel Stack Legal Research, https://law.counselstack.com/opinion/bcbsm-inc-v-walgreen-co-ilnd-2022.